...
机译:COVID-19急性呼吸窘迫综合征:可能的机制和治疗管理
Department of Critical Care Nursing, School of Nursing and Midwifery, Tehran University of Medical Science;
Immunology Research Center, Tabriz University of Medical Sciences;
Department of Immunology, Faculty of Medicine, Tabriz University of Medical SciencesExperimental and Applied Pharmaceutical Research Center, Urmia University of Medical SciencesDepartment of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical SciencesNephrology and Kidney Transplant Research Center, Clinical Research Institute, Urmia University of Medical SciencesHematology, Immune Cell Therapy, and Stem Cell Transplantation Research Center, Clinical Research Institute, Urmia University of Medical Sciences;
ARDS; Acute respiratory distress syndrome; COVID-19; Pandemics; SARS-CoV-2;
机译:Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19
机译:COVID-19 pneumonia and COVID-19 associated acute respiratory distress syndrome: diagnosis and management
机译:Shandong University Reports Findings in Respiratory Distress Syndrome (Integrating network pharmacology and pharmacological evaluation to reveal the therapeutic effects and potential mechanism of S-allylmercapto-N-acetylcysteine on acute …)
机译:planodeanáliseestatísticaparao alveolar Recruitment for acute Respiratory Distress syndrome Trial(aRT)。 Ensaio controlado randomizado